25 top MBA programs ranked by Fortune

Fortune ranked the top MBA programs across the United States in July. 

Advertisement

Business schools are ranked based on starting salaries, how quickly graduates find jobs after graduating and where alumni land in corporate America. Fortune asked 100 MBA programs to participate and 69 programs completed Fortune’s questionnaire. That data, along with information retrieved from companies and executives was used to rank schools.

The top 25 MBA programs:

  1. Harvard University (Boston)
  2. Stanford (Calif.) University
  3. University of Pennsylvania (Philadelphia)
  4. University of Chicago
  5. Northwestern University (Evanston, Ill.)
  6. Columbia University (New York City)
  7. New York University (New York City)
  8. Massachusetts Institute of Technology (Cambridge, Mass.)
  9. Yale University (New Haven, Conn.)
  10. Dartmouth College (Hanover, N.H.)
  11. Duke University (Durham, N.C.)
  12. Cornell University (Ithaca, N.Y.)
  13. University of California – Berkeley
  14. University of Virginia (Charlottesville)
  15. Carnegie Mellon University (Pittsburgh)
  16. University of Texas – Austin
  17. University of North Carolina – Chapel Hill
  18. University of Washington (Seattle)
  19. Georgetown University (Washington, D.C)
  20. Vanderbilt University (Nashville, Tenn.)
  21. Indiana University (Bloomington)
  22. Rice University (Houston)
  23. University of Minnesota – Twin Cities (Minneapolis)
  24. Georgia Institute of Technology (Atlanta)
  25. Texas A&M University – College Station

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Rankings and Ratings

Advertisement

Comments are closed.